National Use of Thrombolysis with Alteplase for Acute Ischaemic Stroke via Telemedicine in Denmark: A Model of Budgetary Impact and Cost Effectiveness

Aim: The purpose of this analysis was to assess the budgetary impact and cost effectiveness of the national use of thrombolysis with alteplase (recombinant tissue plasminogen activator; rt-PA) for acute ischaemic stroke via telemedicine in Denmark. Methods: Computations were based on a Danish health...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs 2008, Vol.22 (1), p.73-81
Hauptverfasser:	Ehlers, Lars, Müskens, Wilhelmina Maria, Jensen, Lotte Groth, Kjølby, Mette, Andersen, Grethe
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Brain Ischemia - complications Budgets Cardiovascular system Cerebral Hemorrhage - epidemiology Cost analysis Cost control Cost of Illness Cost-Benefit Analysis Denmark - epidemiology Drug Costs Drug Utilization Female Fibrinolytic Agents - economics Fibrinolytic Agents - therapeutic use Hospitals Humans Male Medical sciences Medicine Medicine & Public Health Models, Economic Mortality Neurology Neurosciences Original Research Article Patients Pharmacology. Drug treatments Pharmacotherapy Psychiatry Psychopharmacology Quality-Adjusted Life Years Randomized Controlled Trials as Topic Rehabilitation Stroke Stroke - drug therapy Stroke - economics Stroke - epidemiology Studies t-Plasminogen activator Telemedicine Telemedicine - economics Telemedicine - statistics & numerical data Thrombolysis Tissue Plasminogen Activator - economics Tissue Plasminogen Activator - therapeutic use Vascular diseases and vascular malformations of the nervous system Vasodilator agents. Cerebral vasodilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!